Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

F. J. Giles*, N. Vey, D. Rizzieri, F. Ravandi, T. Prebet, G. Borthakur, T. F. Jacobsen, S. Hagen, B. Nilsson, S. O'Brien

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies'. Together they form a unique fingerprint.